These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18001319)

  • 41. Non-traditional biomarkers of atherosclerosis in stable and unstable coronary artery disease, do they differ?
    Konstantino Y; Wolk R; Terra SG; Nguyen TT; Fryburg DA
    Acute Card Care; 2007; 9(4):197-206. PubMed ID: 17924231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein-associated phospholipase A2: an independent predictor of cardiovascular risk and a novel target for immunomodulation therapy.
    Khakpour H; Frishman WH
    Cardiol Rev; 2009; 17(5):222-9. PubMed ID: 19690473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Markers for early detection of cardiac diseases.
    Wu AH
    Scand J Clin Lab Invest Suppl; 2005; 240():112-21. PubMed ID: 16112968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute coronary syndrome.
    Overbaugh KJ
    Am J Nurs; 2009 May; 109(5):42-52; quiz 53. PubMed ID: 19411905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The clinical research of serum soluble CD40L and high sensitivie C-reactive protein in patients with acute coronary syndrome].
    Fu HJ; Yuan M; Ren LF; Guo WY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):180-1. PubMed ID: 21315051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gender-specific differences in biomarkers responses to acute coronary syndromes and revascularization procedures.
    Sbarouni E; Georgiadou P; Voudris V
    Biomarkers; 2011 Sep; 16(6):457-65. PubMed ID: 21851313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes.
    Möckel M; Danne O; Müller R; Vollert JO; Müller C; Lueders C; Störk T; Frei U; Koenig W; Dietz R; Jaffe AS
    Clin Chim Acta; 2008 Jul; 393(2):103-9. PubMed ID: 18423399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Correlation between acute coronary syndrome, hyperlipoproteinemia and statins].
    Panić G; Petrović M; Jovelic A; Dejanović J; Cemerlić-Adić N; Panić M
    Med Pregl; 2009; 62 Suppl 3():33-6. PubMed ID: 19702113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Matrix metalloproteinases in acute coronary syndromes: a new therapeutic target?
    Celik T; Iyisoy A; Kardesoglu E; Bugan B; Isik E
    Int J Cardiol; 2009 May; 134(3):402-4. PubMed ID: 18237788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early statin therapy in elderly patients presenting with acute coronary syndrome causing less heart failure.
    Saab FA; Petrina M; Kline-Rogers E; Fang J; Otten R; Mukherjee D; Eagle KA
    Indian Heart J; 2006; 58(4):321-4. PubMed ID: 19039148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins in acute coronary syndromes: do the guideline recommendations match the evidence?
    Morrissey RP; Diamond GA; Kaul S
    J Am Coll Cardiol; 2009 Oct; 54(15):1425-33. PubMed ID: 19796735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Inflammation in acute coronary syndromes: mechanisms and clinical implications].
    Angiolillo DJ; Biasucci LM; Liuzzo G; Crea F
    Rev Esp Cardiol; 2004 May; 57(5):433-46. PubMed ID: 15151777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome.
    Rosenson RS; Brewer HB; Rader DJ
    Circ Res; 2014 Jun; 114(12):1880-9. PubMed ID: 24902972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.
    Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M
    Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effects of early application of simvastatin on C-reactive protein level, blood lipids, and the clinical course of acute coronary syndrome].
    Shal'nev VI
    Klin Med (Mosk); 2007; 85(11):46-50. PubMed ID: 18219956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
    Bogaty P; Boyer L; Simard S; Dauwe F; Dupuis R; Verret B; Huynh T; Bertrand F; Dagenais GR; Brophy JM
    J Am Coll Cardiol; 2008 Jun; 51(24):2339-46. PubMed ID: 18549920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statins for the treatment of antiphospholipid syndrome?
    Jajoria P; Murthy V; Papalardo E; Romay-Penabad Z; Gleason C; Pierangeli SS
    Ann N Y Acad Sci; 2009 Sep; 1173():736-45. PubMed ID: 19758223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Statins and thrombogenesis].
    Palomäki A
    Duodecim; 2011; 127(20):2131-8. PubMed ID: 22191199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.